Last update: May 7, 2019

Ergotamine Tartrate

Decreased level of risk

New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was High Risk probable, is now set to Low Risk probable.

Level of risk reviewed on May 1, 2019

Low Risk for breastfeeding


Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

Ergot derivative alkaloid. It may inhibit prolactin secretion.

It is used together with other substances (e.g. caffeine, which is a cause of anxiety). Multiple drug association is not recommended.

On latest update relevant data on breastfeeding was not found.

Sumatriptan which is a drug with well known low excretion into breast milk should be an alternative treatment for Migraine.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Ergotamine Tartrate belongs to this group or family:

Tradenames

Main tradenames from several countries containing Ergotamine Tartrate in its composition:

  • Anergan
  • Avamigran
  • Bellataminal (Беллатаминал)™. Contains other elements than Ergotamine Tartrate in its composition
  • Bellergal™. Contains other elements than Ergotamine Tartrate in its composition
  • Bellergal-S™. Contains other elements than Ergotamine Tartrate in its composition
  • Cafatine™. Contains other elements than Ergotamine Tartrate in its composition
  • Cafatine-PB™. Contains other elements than Ergotamine Tartrate in its composition
  • Cafergot™. Contains other elements than Ergotamine Tartrate in its composition
  • Caftar™. Contains other elements than Ergotamine Tartrate in its composition
  • Cefalex Plus™. Contains other elements than Ergotamine Tartrate in its composition
  • Enxak
  • Ercaf™. Contains other elements than Ergotamine Tartrate in its composition
  • Ergocaf™. Contains other elements than Ergotamine Tartrate in its composition
  • Ergodryl M
  • Ergomar
  • Ergotan
  • Hemicraneal™. Contains other elements than Ergotamine Tartrate in its composition
  • Lingraine
  • Migergot™. Contains other elements than Ergotamine Tartrate in its composition
  • Migral™. Contains other elements than Ergotamine Tartrate in its composition
  • Migral Compositum™. Contains other elements than Ergotamine Tartrate in its composition
  • Migral II™. Contains other elements than Ergotamine Tartrate in its composition
  • Migrane™. Contains other elements than Ergotamine Tartrate in its composition
  • Migretil™. Contains other elements than Ergotamine Tartrate in its composition
  • Migril™. Contains other elements than Ergotamine Tartrate in its composition
  • Optium (Mexico)™. Contains other elements than Ergotamine Tartrate in its composition

Pharmacokinetics

Variable Value Unit
Bioavailability 2 (rectal: 5) %
Molecular weight 1.313 daltons
Protein Binding 93 - 98 %
pKa 9,7 - 11,6 -
Tmax 0,5 - 3 hours
T1/2 2 - 21 hours

References

  1. Bordini CA, Roesler C, Carvalho Dde S, Macedo DD, Piovesan É, Melhado EM, Dach F, Kowacs F, Silva Júnior HM, Souza JA, Maciel JA Jr, Carvalho JJ, Speciali JG, Barea LM, Queiroz LP, Ciciarelli MC, Valença MM, Lima MM, Vincent MB. Recommendations for the treatment of migraine attacks - a Brazilian consensus. Arq Neuropsiquiatr. 2016 Abstract Full text (link to original source) Full text (in our servers)
  2. Davanzo R, Bua J, Paloni G, Facchina G. Breastfeeding and migraine drugs. Eur J Clin Pharmacol. 2014 Abstract
  3. Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ; Canadian Headache Society Acute Migraine Treatment Guideline Development Group.. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013 Sep;40(5 Suppl 3):S1-S80. Review. Abstract
  4. Sandoz. Ergotamine (Cafergot). Drug Summary. 2012 Full text (in our servers)
  5. Duong S, Bozzo P, Nordeng H, Einarson A. Safety of triptans for migraine headaches during pregnancy and breastfeeding. Can Fam Physician. 2010 Abstract Full text (link to original source) Full text (in our servers)
  6. Jürgens TP, Schaefer C, May A. Treatment of cluster headache in pregnancy and lactation. Cephalalgia. 2009 Abstract
  7. AEMPS - Amdipharm. Ergotamina (Cafergot). Ficha técnica. 2009 Full text (in our servers)
  8. Raña-Martínez N. Migraña en la mujer. [Migraine in females]. Rev Neurol. 2008 Abstract
  9. MacGregor EA. Migraine in pregnancy and lactation: a clinical review. J Fam Plann Reprod Health Care. 2007 Abstract Full text (in our servers)
  10. Loder E. Migraine in pregnancy. Semin Neurol. 2007 Abstract
  11. Moretti ME, Lee A, Ito S. Which drugs are contraindicated during breastfeeding? Practice guidelines. Can Fam Physician. 2000 Sep;46:1753-7. Review. Abstract Full text (link to original source) Full text (in our servers)
  12. Wojnar-Horton RE, Hackett LP, Yapp P, Dusci LJ, Paech M, Ilett KF. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol. 1996 Abstract Full text (link to original source) Full text (in our servers)
  13. Jolivet A, Robyn C, Huraux-Rendu C, Gautray JP. [Effect of ergot alkaloid derivatives on milk secretion in the immediate postpartum period]. J Gynecol Obstet Biol Reprod (Paris). 1978 Jan;7(1):129-34. French. Abstract

Total visits

46,849

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM